Navigation Links
BioCryst Updates Peramivir Clinical Development Plan
Date:1/23/2008

BIRMINGHAM, Ala., Jan. 23 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today provided an update on activities conducted following release of the preliminary Phase II data and outlined the resulting clinical development plan for intramuscular (i.m.) peramivir.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030414/BIOCRYSTLOGO )

Following release of preliminary Phase II results in September 2007, the Company completed additional analyses of the clinical data and performed a preliminary analysis of the virologic data from this trial. The Company also conducted further pharmacokinetic (PK) studies in healthy volunteers and has had discussions with the FDA and The Department of Health and Human Services (HHS) in support of the continuing development of peramivir.

Preliminary analysis of the virologic data from the Phase II trial indicated that i.m. peramivir demonstrated statistically significant reductions in influenza virus shedding in both active treatment groups when compared to placebo, with greater reductions in the 300mg group (p<0.001). Additionally, pharmacokinetic studies have been completed that indicate that needle length impacts adequate and consistent systemic exposure to i.m. peramivir. These PK studies also provide guidance on the appropriate needle length to use in future studies to provide adequate drug exposure for subjects based upon an individual's body mass index (BMI) and gender.

Based on these clinical results and virologic data, the Company believes that a single i.m. dose of 300mg peramivir can be a potentially clinically effective dose. Given the dose-response observed between the
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2. BioCryst Provides Forodesine HCl Update
3. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
4. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
5. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
6. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
7. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
8. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... SAN FRANCISCO , Aug. 21, 2014 ... U.S. Food and Drug Administration (FDA) has ... to detect atrial fibrillation (AFib), the most ... analysis process (algorithm) instantly detects if patients ... recordings taken on the mobile phone based ...
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis ... three independent members to its Board of Directors, ... experience of the company, a leading licensed producer ... . Internationally, Bedrocan has 13 years, experience in ... in seven countries, including Canada. ...
Breaking Medicine Technology:AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3
... BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ -- Sinovac Biotech Ltd. (Nasdaq: ... products in China, announced today that it has been ... Prevention (Beijing CDC) as one of the five manufacturers ... Beijing. As part of the bidding process, ...
... 24 The National Community Pharmacists ... Jaeger as Executive Vice President and CEO, heralding ... the association,s recent accomplishments and lead it to ... of, independent community pharmacies and the patients they ...
Cached Medicine Technology:Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 2Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 3NCPA Announces Kathleen Jaeger as CEO 2
(Date:8/21/2014)... Home Care Assistance of Centennial , a ... has received the Certified – Trusted Provider distinction from ... commitment to client satisfaction. , “Our goal at Home ... the South Metro Denver area are receiving the best ... Care Assistance of Centennial. “Home Care Pulse not ...
(Date:8/21/2014)... health authorities need to ensure that experimental drugs to ... of randomized controlled trials, according to a new Viewpoint, ... August, 2014]. , Leading bioethicists Professor Ezekiel ... Dr Annette Rid, of King,s College London, UK, outline ... if experimental drugs are to be deployed in the ...
(Date:8/21/2014)... 2014 Dr. Vasili Gatsinaris, ... was recently recognized as one of the ... field of workers’ compensation. , The list ... Occupational Medicine Conference was created by polling ... case managers, disability specialists, physical therapists, rehabilitation ...
(Date:8/21/2014)... 21, 2014 According to a new ... Optics Market-Global Industry Analysis, Size, Share, Growth, Trends and ... market was valued at USD 863.1 million in 2013 ... 7.6% from 2013 to 2019, to reach an estimated ... medical fiber optics market is witnessing significant growth due ...
(Date:8/21/2014)... 21, 2014 The worlds of personal ... an exciting chance to grab free products. BaliniSports ... from Tom's of Maine with all qualifying purchases for ... our environmentally friendly yoga apparel is simply perfect,” said ... promotion between the two brands is intended to give ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 2Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 3Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Dr. Vasili Gatsinaris Named One of the Top 50 Most Influential in Workers’ Compensation 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2
... 25 Videos Airing on Exclusive Statewide On-Demand Channel, ... the winner of the YouCare video contest. Rachel Sbrissa ... video that shares why,she chooses not to smoke. Sbrissa,s ... radiation for lung cancer when the,video was being created, ...
... Popular Series Begin Monday, July 14, on ... Television,s Home for Medical Mysteries -, SILVER SPRING, ... emergency room stories to television with,MYSTERY ER, the popular medical ... second season premieres 10 suspense-packed episodes,showcasing the life-threatening drama of ...
... - Company Expects to Submit Complete Response by ... 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) ... response from,the U.S. Food and Drug Administration (FDA) ... the Agency,s Approvable Letter for its once-daily,tramadol formulation ...
... insurance consulting service reports that "Republican candidate John ... to buying a computers or cars" saying competition ... care proposal of the presumptive Republican presidential nominee ... employer-sponsored system; it will make things worse, said ...
... autism spectrum disorder (ASD) frequently struggle to fit into a world ... find for adults than for children. SIMmersion LLC is hoping ... of its simulation software catered to practicing and strengthening communication skills. ... ...
... to reduce pain in newborns undergoing painful procedures ... (venipuncture) for the newborn screening test but not ... co-authors. , In this double-blind, randomized controlled ... Hospital, researchers found that "sucrose reduced overall pain ...
Cached Medicine News:Health News:Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 3Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 2Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 3Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 2Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 3Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 2Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: